Garofalo Health Care
ISIN
IT0005345233
Ticker
GHC
Sector
Sub-Industry
Country
Italy
Year Founded
2000
ISIN
IT0005345233
Ticker
GHC
Sector
Sub-Industry
Country
Italy
Year Founded
2000
GHC - Garofalo Health Care S.p.A. is a leading group, in the field of private accredited healthcare, listed on the Euronext STAR segment of the Italian Stock Exchange and based in Rome, Italy. The qualities and strengths that make the Group unique are diverse and can be distinguished by the following characteristics:
Territorial diversification. GHC represents 32 centres of excellence located in some of the most prosperous regions of Northern and Central Italy: Piedmont, Lombardy, Veneto, Friuli Venezia Giulia, Liguria, Emilia Romagna, Tuscany, Lazio. The professionals and medical teams of each centre constantly and consistently collaborate with each other in terms of research activities and direct operating methods, with the aim of better protecting the patient’s health.
1,872
Italy
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Cash and cash equivalents | 27,763,000.00 | 24,810,000.00 | 41,239,000.00 | 31,382,000.00 |
| Statutory Reserve | N/A | 394,000.00 | 471,000.00 | 532,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 326,000.00 | 0.00 | N/A |
| Other Noncurrent Liabilities | N/A | 360,000.00 | 213,000.00 | 3,208,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Other Revenue | 4,068,000.00 | 5,803,000.00 | 7,810,000.00 |
| Revenue From Contracts With Customers | 206,778,000.00 | 277,869,000.00 | 314,764,000.00 |
| Services Expense | 88,229,000.00 | 118,407,000.00 | 134,032,000.00 |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 11,807,000.00 | 15,706,000.00 | 18,963,000.00 |
| Profit (loss) | 11,784,000.00 | 18,843,000.00 | 21,433,000.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 11,784,000.00 | 18,843,000.00 | 21,433,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -2,953,000.00 | 16,429,000.00 | -9,857,000.00 |
| Cash and cash equivalents | 27,763,000.00 | 24,810,000.00 | 41,239,000.00 | 31,382,000.00 |
Please note that some sums might not add up.
IT0005345233
815600C851C90CAE6438
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.